Vanguard Group Inc Castle Biosciences Inc Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,172,318 shares of CSTL stock, worth $72.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,172,318

Previous 2,170,028 0.11%

Holding current value

$72.7 Million

Previous $44.3 Million 11.63%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$14.65 - $24.65 $33,548 - $56,448	2,290 Added 0.11%	2,172,318 $49.5 Million
Q2 2025 Aug 11, 2025	BUY	$15.8 - $21.98 $1.93 Million - $2.69 Million	122,463 Added 5.98%	2,170,028 $44.3 Million
Q1 2025 May 09, 2025	BUY	$18.76 - $32.72 $4.03 Million - $7.04 Million	215,030 Added 11.73%	2,047,565 $41 Million
Q4 2024 Feb 11, 2025	BUY	$26.52 - $34.67 $2.22 Million - $2.9 Million	83,783 Added 4.79%	1,832,535 $48.8 Million
Q3 2024 Nov 13, 2024	BUY	$17.4 - $31.47 $2.98 Million - $5.39 Million	171,238 Added 10.85%	1,748,752 $49.9 Million

Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $1.57 Million - $2.08 Million	83,338 Added 5.58%	1,577,514 $34.3 Million
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $590,471 - $827,183	32,695 Added 2.24%	1,494,176 $33.1 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $269,313 - $495,545	22,093 Added 1.53%	1,461,481 $31.5 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $158,921 - $242,930	11,967 Added 0.84%	1,439,388 $24.3 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $274,243 - $611,520	23,520 Added 1.68%	1,427,421 $19.6 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $217,616 - $318,432	11,177 Added 0.8%	1,403,901 $31.9 Million
Q4 2022 Feb 10, 2023	BUY	$18.08 - $30.0 $2.57 Million - $4.26 Million	141,991 Added 11.35%	1,392,724 $32.8 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $898,981 - $1.37 Million	39,937 Added 3.3%	1,250,733 $32.6 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $553,104 - $1.59 Million	34,569 Added 2.94%	1,210,796 $26.6 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $444,013 - $628,874	13,386 Added 1.15%	1,176,227 $52.8 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $130,733 - $226,190	-3,347 Reduced 0.29%	1,162,841 $49.9 Million
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $2.34 Million - $3.03 Million	38,996 Added 3.46%	1,166,188 $77.6 Million
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $56.4 Million - $86.5 Million	1,127,192 New	1,127,192 $82.7 Million

Others Institutions Holding CSTL

# of Institutions

185

Shares Held

27M

Call Options Held

42.2K

Put Options Held

9.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $880M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Castle Biosciences Inc Transaction History